drug
vestronidase alfa
Marketedupdated 5mo agoby $RARE Ultragenyx Pharmaceutical Inc.
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying vestronidase alfa
News(2)
- Milestone Sanfilippo nod helps Ultragenyx regroup after tough Angelman defeatThe recent FDA approval of Fayuvi for a rare, childhood neurodegenerative disease was “particularly special” for Ultragenyx CEO Emil Kakkis. It could also, along with an August nod for another gene…biospace · 6d ago
- Biotechs bring big launches and pharma rivalries into Q2 earnings periodWith the second quarter earnings period underway, BioSpace examines five biotechs with meaningful catalysts that analysts and investors are watching.biospace · 2mo ago
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that